(Reuters) - A closely watched blood clot preventer from Bristol-Myers Squibb Co and Pfizer Inc has failed to win approval from U.S. health regulators, the companies said on Monday. Investors have been awaiting a decision on the drug, Eliquis, by the Food And Drug Administration by the end of the month. The FDA notification did not require the companies to complete any new studies, the companies said, which could mean only a short delay before the drug wins approval. Rather, the agency wants more information on data management and verification from a key clinical trial supporting the medicine. ... read more..
Tuesday, 26 June 2012
Food And Drug Administration-Blood Clot Preventer-Bristol-Myers Squibb-Health Regulators
Tuesday, 8 May 2012
Food And Drug Administration-Rheumatoid Arthritis Drug-Advisory Panel-Side Effects
WASHINGTON (Reuters) - Pfizer Inc's experimental rheumatoid arthritis drug goes before an advisory panel next week, a potential blockbuster medicine that would revive faith in the company's research if its benefits are deemed to outweigh its Side Effects. Most industry analysts expect the Food And Drug Administration's expert committee to recommend approval despite risks posed by higher-than-normal cholesterol and liver enzyme levels and infections for patients taking tofacitinib during clinical trials. ... read more..
Throwing together a salad for dinner tonight? Make these simple swaps to keep yo...
Throwing together a salad for dinner tonight? Make these simple swaps to keep your healthy dinner from turning into a calorie bomb!
My Salad Has How Many Calories!?
Save hundreds of calories with these slimming salad swaps. read more..